OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit

Investors Urged to Take Lead in OM Lawsuit

LOS ANGELES, Sept. 27, 2024 — Glancy Prongay & Murray LLP (“GPM”) highlights an opportunity for investors facing losses to spearhead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) with the ticker symbol OM.

Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024

If interested in leading the Outset Medical lawsuit, you can register your contact information at Glancy Prongay’s website. Alternatively, reach out to Charles H. Linehan, of GPM, via phone at 310-201-9150, Toll-Free at 888-773-9224, or through email at shareholders@glancylaw.com for further details.

Allegations and Claims

The complaint suggests that during the Class Period, Defendants concealed vital information from investors about Outset Medical’s Tablo products. Issues included improper marketing for continuous renal replacement therapy, non-FDA approved indications, potential additional applications, sales risks pending FDA approval, insufficient sales infrastructure, adverse revenue growth forecasts, and misleading statements about the Company’s status.

For updates, you can follow Glancy Prongay & Murray LLP on LinkedIn, Twitter, or Facebook.

To be part of the class action, no immediate action is required. You can consult your preferred counsel or remain a passive member. For more details or inquiries, contact Charles Linehan, Esquire, of GPM, at 310-201-9150 or Toll-Free at 888-773-9224, via email at shareholders@glancylaw.com, or by visiting Glancy Prongay’s website.

Note: This press release may be deemed Attorney Advertising in specific jurisdictions as per relevant laws and ethical standards.

Contacts: Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan: 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
Website: www.glancylaw.com

The pulse of consumer and business finances beats steadily, underlying a vigorous economic landscape poised for further growth.

Deutsche Bank's Binky Chadha noted the robust state of household and corporate balance sheets, diverging significantly from historical downturns, setting the stage for continued economic momentum.

While debt levels capture attention, the critical measure is how this debt aligns with the capacity for its servicing, a metric that stands historically resilient.

Amidst prevailing pessimistic sentiment among consumers and business executives, data shines a light on their steadfast expenditure patterns, guided by robust financial capabilities.

The Stock Market: Unshackled from Trump's Influence

Conventional wisdom once heralded Donald Trump's policy agenda as a boon for the stock market compared to his Democratic counterparts. However, recent events unveil a shift in this narrative.

RBC's Lori Calvasina highlighted a decoupling between stock market trends and Trump's electoral odds, signaling a divergence from previous expectations tied to political outcomes.

History illustrates how amid contentious policy reforms, corporations showcased resilience in enhancing earnings, an encouraging precedent in the current scenario.

The Power of Compound Interest: Beyond Political Partisanship

Delving into the impact of political affiliations on investment outcomes, insights reveal a marginal variance in returns between Democratic and Republican presidential tenures.

However, investors maintaining a steadfast stance irrespective of the White House occupant significantly outperformed, showcasing the supremacy of consistent market participation in wealth accumulation.

BlackRock's Gargi Chaudhuri emphasizes the pivotal role of continuous investment, underscoring the transformative influence of compound interest in creating enduring prosperity.

U.S. Corporate Dominance: A Tale of Unparalleled Success

Reflecting on Mario Draghi's discerning analysis of European competitiveness, Jim Reid of Deutsche Bank accentuates the dynamic landscape favoring U.S. corporations over their European counterparts.

Highlighting the dearth of EU firms surpassing €100 billion market capitalization within the last 50 years, the allure of American business prowess stands evocatively eminent.

The distinct essence of innovation, business-friendly regulations, and robust corporate governance principles in the U.S. market herald a golden era of prosperity and growth.

A Glimpse into Financial Insights Insights into Financial Trends: A Deep Dive into Market Dynamics

Market News and Data brought to you by Benzinga APIs